FRANKFURT () -Swiss drugmaker Novartis, on a deal-making spree this year, reported a gain in operating income of 6% as growth ...

Building products manufacturer Simpson (NYSE:SSD) announced in Q3 CY2025, with sales up 6.2% year on year to $623.5 million.

From a shocking financial metric to an unprecedented plug for the CEO's pay package, the electric vehicle maker's earnings ...

Olin (OLN) shows strong turnaround progress with margin gains, solid dividend, and 25% upside potential. Read here for more ...

S&P 500 surges as Magnificent 7 tech giants, Fed rate cut, and AI boom fuel record earnings. Get expert insights on market ...

Amundi , Europe's biggest asset manager, reported slightly higher-than-expected net inflows in the third quarter on Tuesday, ...

Nucor (NYSE: NUE) delivered a decisive earnings beat on Monday evening, posting Q3 results that significantly exceeded ...

The Indian pharmaceutical and healthcare sector saw robust deal activity in Q3, with 72 transactions totaling USD 3.5 billion ...

Live Updates Live Coverage Updates appear automatically as they are published. Get The Best Celestica Live Earnings Coverage ...

Sales growth was driven by continued strong execution on priority brands including Kisqali (+68% cc), Kesimpta (+44% cc), Pluvicto (+45% cc) and Scemblix (+95% cc) Core operating income margin 1 was ...

It records net inflows of S$736 million in the quarter, bringing the total to S$1.4 billion in the year to date Read more at ...

India's pharma and healthcare sector recorded $3.5 billion in Q3 2025, driven by 72 transactions, says Grant Thornton Bharat.